Research Activities
Our programs, projects and other research activities tackle ongoing challenges in translational research so that new treatments and other health solutions can reach people faster.
Research Activities at NCATS
Through our research activities, we overcome roadblocks that slow progress on developing treatments for many different diseases and that can lead to inequities in clinical outcomes. Explore the range of initiatives we support at NCATS and beyond.
Illuminating the Druggable Genome (IDG)
We help lead this NIH Common Fund program to study and generate resources on key targets for new therapeutic agents.
Informatics
Our team works with scientists to make sense of data from large experiments to inform decisions that advance translational research.
More About Informatics
LitCoin
LitCoin helps the NIH share data by giving researchers a way to get recognized for sharing their data and findings through scientific papers.
Matrix Combination Screening
Our experts use matrix combination screening technology to quickly identify promising drug combinations with the most potential to help patients.
More About Matrix
MMA-101
This project will test a gene therapy as a potential treatment for a rare genetic disorder.
Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
This grant program funds the development of innovative approaches for reducing the time it takes to accurately diagnose rare diseases.
More About Multidisciplinary Machine-Assisted, Genomic Analysis
National COVID Cohort Collaborative (N3C)
We created and maintain this national resource of clinical and other data to answer critical research questions about COVID-19 health outcomes.
More About N3C
NIH Quantum Biomedical Innovations and Technologies (Qu-BIT) Program
Qu-BIT aims to further the application of innovative novel quantum-enabled sensing technologies and quantum computing approaches for various biomedical and translational use cases purposes.
OpenDataPortal
Our OpenData Portal is an open and accessible platform for sharing COVID-19-related drug repurposing data and experiments involving approved drugs.
More About OpenData Portal
Platform Vector Gene Therapy (PaVe-GT)
Our pilot project is testing the feasibility of increasing the efficiency of gene therapy clinical trials by using the same gene delivery system and manufacturing methods for multiple gene therapies.
More About the PaVe-GT
Preclinical Chemical Biology Laboratory
Our scientists and collaborators bridge chemistry and the biology underlying disease to develop new ways to discover and create chemical probes and potential drug candidates.
Rare Diseases Clinical Research Network (RDCRN)
We oversee this NIH-wide grant program that supports medical research on over 200 rare diseases through clinical studies, including collaborations, study enrollment and data sharing.
More About the RDCRN
RARe-SOURCE™
RARe-SOURCE™ aims to collect and combine several data sources to build an integrated bioinformatics resource. This will address the challenges in rare disease research.
Somatic Cell Genome Editing [NIH Common Fund Programs]
We help lead this NIH Common Fund program that aims to create and make available high-quality tools for safe and effective genome editing to decrease the time and cost of creating new therapies.
More About Somatic Cell Genome Editing
Stem Cell Translation Laboratory (SCTL)
Our experts develop methods and standards to use stem cell technology (using cells derived from skin or blood) to advance treatment approaches.
More About the SCTL